![Debra Zack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Debra Zack
Hoofd Techniek/Wetenschap/O&O bij
SPERO THERAPEUTICS, INC.
Vermogen: 189 904 $ op 31-07-2026
Profiel
Debra Jeske Zack is currently Chief Medical Officer at Spero Therapeutics, Inc. since 2026.
Former positions include Chief Medical Officer at Exagen, Inc. from 2020 to 2022, Executive Director-Global Product Area at Amgen, Inc., Vice President-Clinical Development at Xencor, Inc., and Associate Professor at the University of California, Los Angeles.
Education includes undergraduate studies at Texas Christian University and a doctorate from The University of Texas Southwestern Medical Center.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-08-2026 | 162.311 ( 0,28% ) | 189 904 $ | 31-07-2026 |
Actieve functies van Debra Zack
| Bedrijven | Functie | Begin |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 27-07-2026 |
Eerdere bekende functies van Debra Zack
| Bedrijven | Functie | Einde |
|---|---|---|
| EXAGEN INC. | Hoofd Techniek/Wetenschap/O&O | 05-12-2022 |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
| XENCOR, INC. | Corporate Officer/Principal | - |
Opleiding van Debra Zack
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
22
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Texas Christian University
 Texas Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exagen, Inc.
 Exagen, Inc. Medical/Nursing ServicesHealth Services Operates as a commercial-stage diagnostics company | Health Services |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
